11. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016. (August 2016) Authors: Garbe, Claus; Peris, Ketty; Hauschild, Axel; Saiag, Philippe; Middleton, Mark; Bastholt, Lars; Grob, Jean-Jacques; Malvehy, Josep; Newton-Bishop, Julia; Stratigos, Alexander J.; Pehamberger, Hubert; Eggermont, Alexander M. Journal: European journal of cancer Issue: Volume 63(2016) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics – Update 2019. (February 2020) Authors: Garbe, Claus; Amaral, Teresa; Peris, Ketty; Hauschild, Axel; Arenberger, Petr; Bastholt, Lars; Bataille, Veronique; del Marmol, Veronique; Dréno, Brigitte; Fargnoli, Maria Concetta; Grob, Jean-Jacques; Höller, Christoph; Kaufmann, Roland; Lallas, Aimilios; Lebbé, Celeste; Malvehy, Josep; Middleto... Journal: European journal of cancer Issue: Volume 126(2020) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019. (February 2020) Authors: Garbe, Claus; Amaral, Teresa; Peris, Ketty; Hauschild, Axel; Arenberger, Petr; Bastholt, Lars; Bataille, Veronique; del Marmol, Veronique; Dréno, Brigitte; Fargnoli, Maria Concetta; Grob, Jean-Jacques; Höller, Christoph; Kaufmann, Roland; Lallas, Aimilios; Lebbé, Celeste; Malvehy, Josep; Middleto... Journal: European journal of cancer Issue: Volume 126(2020) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Final planned overall survival (OS) from OPTiM, a randomized Phase III trial of talimogene laherparepvec (T-VEC) versus GM-CSF for the treatment of unresected stage IIIB/C/IV melanoma (NCT00769704). (6th November 2014) Authors: Andtbacka, Robert HI; Collichio, Frances A; Amatruda, Thomas; Senzer, Neil; Chesney, Jason; Delman, Keith; Spitler, Lynn; Puzanov, Igor; Agarwala, Sanjiv; Milhem, Mohammed; Harrington, Kevin; Middleton, Mark; Li, Ai; Shilkrut, Mark; Coffin, Robert; Kaufman, Howard Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors. Issue 2 (10th January 2021) Authors: Baird, Richard D.; Linossi, Constanza; Middleton, Mark; Lord, Simon; Harris, Adrian; Rodón, Jordi; Zitt, Christof; Fiedler, Ulrike; Dawson, Keith M.; Leupin, Nicolas; Stumpp, Michael T.; Harstrick, Andreas; Azaro, Analía; Fischer, Stefanie; Omlin, Aurelius Journal: Journal of clinical oncology Issue: Volume 39:Issue 2(2021) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity. (March 2019) Authors: Postel-Vinay, Sophie; Herbschleb, Karin; Massard, Christophe; Woodcock, Victoria; Soria, Jean-Charles; Walter, Annette O.; Ewerton, Flavio; Poelman, Martine; Benson, Neil; Ocker, Matthias; Wilkinson, Gary; Middleton, Mark Journal: European journal of cancer Issue: Volume 109(2019) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. NY‐ESO‐1 specific antibody and cellular responses in melanoma patients primed with NY‐ESO‐1 protein in ISCOMATRIX and boosted with recombinant NY‐ESO‐1 fowlpox virus. Issue 6 (14th August 2014) Authors: Chen, Ji‐Li; Dawoodji, Amina; Tarlton, Andrea; Gnjatic, Sacha; Tajar, Abdelouahid; Karydis, Ioannis; Browning, Judy; Pratap, Sarah; Verfaille, Christian; Venhaus, Ralph R.; Pan, Linda; Altman, Douglas G.; Cebon, Jonathan S.; Old, Lloyd L.; Nathan, Paul; Ottensmeier, Christian; Middleton, Mark; Ce... Journal: International journal of cancer Issue: Volume 136:Issue 6(2015:Mar. 15) Page Start: E590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. P-OGC08 Translational Insights from the Dual ErbB Inhibition in Oesophago-gastric Cancer (DEBIOC) Clinical Trial - A Bioinformatic Analysis. (16th December 2021) Authors: Scanlon, Enya; Lavery, Anita; Stevenson, Leanne; Kennedy, Chloe; Byrne, Ryan; Walker, Andrew; Eatock, Martin; Middleton, Mark; Thomas, Anne; Turkington, Richard Journal: British journal of surgery Issue: Volume 108:Supplement 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. PTU-061 Immunotherapy-related gastritis in a tertiary oncology centre. (June 2019) Authors: Cheung, Vincent; Gupta, Tarun; Ye, Weiyu; Middleton, Mark; Fairfax, Ben; Payne, Miranda; Brain, Oliver Journal: Gut Issue: Volume 68(2019)Supplement 2 Page Start: A147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Results of first-in-man proof of concept study of ultrasound-triggered drug delivery in liver tumours. (October 2019) Authors: Lyon, Paul C.; Gray, Michael; Mannaris, Christophoros; Folkes, Lisa; Stratford, Michael; Campo, Leticia; Chung, Daniel; Scott, Shaun; Anderson, Mark; Goldin, Robert; Carlisle, Robert; Wu, Feng; Middleton, Mark; Gleeson, Fergus; Coussios, Constantin Journal: Clinical radiology Issue: Volume 74(2019)Supplement 2 Page Start: e20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗